首页> 外文期刊>Cardiovascular Research >Ultrasound stimulation restores impaired neovascularization-related capacities of human circulating angiogenic cells
【24h】

Ultrasound stimulation restores impaired neovascularization-related capacities of human circulating angiogenic cells

机译:超声刺激可恢复人循环血管生成细胞受损的新血管生成相关能力

获取原文
获取原文并翻译 | 示例
           

摘要

Aims Unsatisfactory effects of therapeutic angiogenesis in critical limb ischaemia may be ascribed to use of circulating angiogenic cells (CACs) derived from atherosclerotic patients with impaired neovascularization-related capacities. We tested whether ultrasound cell stimulation can restore the impaired capacities. Methods and resultsDuring culture of human peripheral blood-derived mononuclear cells for 4 days to achieve CACs, we stimulated the cells in culture daily with low-intensity pulsed ultrasound stimulation (LIPUS). Application of LIPUS to cells in culture derived from healthy volunteers augmented the generation and migration capacities of CACs, increased concentrations of angiopoietin 2 and nitrogen oxides in the culture medium, and increased the expression of phosphorylated-Akt and endothelial nitric oxide synthase in CACs on western blotting. Application of LIPUS to cells in culture derived from atherosclerotic patients also augmented the generation and migration capacities of CACs. Although neovascularization in the ischaemic hindlimb of athymic nude mice was impaired after intramuscular injection of CACs derived from atherosclerotic patients compared with that using CACs derived from healthy volunteers, LIPUS of the cells in culture derived from atherosclerotic patients restored the neovascularization capacities. ConclusionTherapeutic angiogenesis with LIPUS-pre-treated CACs may be a new strategy to rescue critical limb ischaemia in atherosclerotic patients.
机译:目的在严重肢体缺血中治疗性血管生成的效果不理想,可能归因于使用了来自新生血管形成相关能力受损的动脉粥样硬化患者的循环血管生成细胞(CAC)。我们测试了超声细胞刺激是否可以恢复受损的能力。方法和结果在人类外周血来源的单核细胞培养4天以达到CAC的过程中,我们每天用低强度脉冲超声刺激(LIPUS)刺激培养的细胞。将LIPUS应用于健康志愿者培养的细胞中可提高CAC的生成和迁移能力,增加培养基中血管生成素2和氮氧化物的浓度,并增加磷酸化Akt和内皮型一氧化氮合酶的表达。印迹。将LIPUS应用于源自动脉粥样硬化患者的培养细胞中,也可以提高CAC的生成和迁移能力。尽管与使用健康志愿者的CAC相比,肌肉注射源自动脉粥样硬化患者的CAC后,无胸腺裸鼠缺血后肢的新血管形成受到了损害,但源自动脉粥样硬化患者的培养物中细胞的LIPUS恢复了新血管形成的能力。结论LIPUS预处理的CAC治疗血管新生可能是挽救动脉粥样硬化患者严重肢体缺血的一种新策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号